Corient Capital Partners’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$224K Hold
1,902
0.02% 575
2022
Q2
$224K Buy
1,902
+142
+8% +$20.4K 0.02% 585
2022
Q1
$251K Buy
1,760
+80
+5% +$12.2K 0.02% 610
2021
Q4
$283K Sell
1,680
-39
-2% -$6.35K 0.02% 544
2021
Q3
$259K Buy
1,719
+111
+7% +$17.1K 0.02% 544
2021
Q2
$244K Buy
1,608
+136
+9% +$21.6K 0.02% 560
2021
Q1
$220K Buy
+1,472
New +$202K 0.02% 537
2020
Q2
Sell
-3,969
Closed -$291K 498
2020
Q1
$291K Buy
3,969
+30
+0.8% +$2.97K 0.05% 299
2019
Q4
$485K Sell
3,939
-543
-12% -$66.8K 0.06% 285
2019
Q3
$548K Sell
4,482
-11,099
-71% -$1.25M 0.08% 243
2019
Q2
$1.68M Sell
15,581
-2,261
-13% -$234K 0.26% 99
2019
Q1
$1.76M Buy
+17,842
New +$1.76M 0.29% 102

Other funds holding CE

Corient Capital Partners's CE Position: Q3 2022 in Review

Corient Capital Partners held its Celanese (CE) position steady in Q3 2022 at 1,902 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #575.

Corient Capital Partners first reported a position in CE in Q1 2019 and has held it in 12 quarters since. The position peaked at $1.76M in Q1 2019. 633 funds tracked by Wall St. Rank hold CE as of Q3 2022.

  • Corient Capital Partners held 1,902 shares of Celanese worth $224K as of Q3 2022.
  • Corient Capital Partners left its Celanese share count unchanged in Q3 2022.
  • Celanese made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #575 holding.
  • Corient Capital Partners first reported a position in Celanese in Q1 2019 and has held it in 12 quarters since.
  • Corient Capital Partners's Celanese position peaked at $1.76M in Q1 2019.
  • 633 funds tracked by Wall St. Rank held Celanese as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.